Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Pharmacol Biochem Behav. 2011 Dec 17;101(1):125–131. doi: 10.1016/j.pbb.2011.12.009

Table 1.

Curcumin table.

Name Description % Curcumin in chow Curcumin intake (mg/kg day)a Plasma curcumin concentration (μM) Survival (days)
Chromadex 99% pure curcumin from turmeric powder mixed at 20,000 ppm with NIH 7013 base chow 2% 3500 <0.1b,f 84.3±2.0**
Acros 85% pure curcumin from turmeric powder mixed at 2000 ppm with 5P14 base chowe. Harlan Teklad TD.09288. 0.17% 298 0.305±0.164c 83.8±3.8
NIH 7013 Modified 6% mouse/rat sterilizable diet 0% 0 NDd 72.6±2.6
Lipidated Curcumin Verdure Sciences Lot 024908G2711CLEG 0.25% proprietary mixture of curcumin with stearic acid and phosphatidyl choline mixed with NIH 7013 base chow 0.05% 88 0.044±0.017c 77.6±1.4
Lipidated vehicle Proprietary mixture of stearic acid and phosphatidyl choline (Verdure Sciences) made in 5P14 base chowe. Harlan Teklad TD.09288 0% 0 0c 86.2±1.9**
**

p<0.01 against NIH 7013.

a

Curcumin intake was calculated using weights of 20 g per mouse, which for Npc1−/− mice is their peak weight.

b

Laboratory 1.

c

Laboratory 2.

d

Not determined.

e

5P14 similar to 7013 except has slightly higher protein and less fat than NIH 7013.

f

No blood from group. Separate group of animals fed same dose. Subtle differences in curcumin chow preparation may have affected absorption.